MedMen — over 490 layoffs
Company: MedMen
What it does: Cannabis cultivator and retail chain
Layoffs: 190, or 20% of its employees, on November 15. An additional 20% were laid off on December 11, amounting to more than 40% of its corporate workforce over the course of a month. 128 positions terminated in February, and another 170 terminated in April, per a securities filing.
What went wrong: The hits keep coming for the cash-starved MedMen. The company announced it laid off 190 employees in November, including 80 corporate-level employees, in a push to be cash-flow positive by the end of 2020. The company laid off an additional 20% on December 11.
And in February, MedMen terminated 128 employees, according to a Canadian Securities Exchange filing.
In April, MedMen said it cut 170 positions and added 9 in the month, per a securities filing.
MedMen is also planning to sell off stakes it bought in cannabis brands — which it says will net the company $8 million – and has engaged Canaccord Genuity to “explore strategic alternatives” for cultivation licenses and stores “not deemed critical to the company’s retail footprint.”
The layoffs come amid a months-long restructuring plan put into place by the company’s board and former CEO Adam Bierman. MedMen has engaged a turnaround firm, FTI Consulting, to assist with the process.
On top of all that, MedMen announced earlier in November that it was selling its stake in Treehouse, a cannabis real estate investment trust.
In the past few months, MedMen has been hit with a litany of lawsuits and top executives departing, including David Dancer, the former CMO, and Michael Kramer, the former CFO.